Overview
Annee is a graduate student in Duke's Department of Pharmacology, a joint program with Molecular Cancer Biology. She is excited to identify therapeutic molecules and elucidate therapeutic mechanisms of antitumor efficacy that may also target secondary comorbid conditions, such as pain or neurological deficits. She is passionate about scientific education and communication and hopes to remain in academia with the goal of cultivating the next generation of scientists.
In 2017, Annee graduated from the University of California, San Diego, from Warren College, with a Bachelor of Science in Human Biology (double minoring in Psychology and Theatre) as magna cum laude and as part of the Sigma Chapter of the Phi Beta Kappa Society and obtained a contiguous Master of Science in Biology in 2018, concentrating in Neuropathology and Scientific Communication.
Since 2014, her prior research experience includes working with various preclinical models of peripheral neuropathy (with Dr. Nigel Calcutt and Dr. Christina Sigurdson of UC San Diego’s Department of Pathology), equine and murine models of neuroaxonal dystrophy (with Dr. Carrie Finno of UC Davis’s School of Veterinary Medicine), and CNS tumor preclinical models of recurrent glioblastoma and spine tumors and metastases at Duke University Medical Center with Dr. Rory Goodwin of the Duke Center for Brain and Spine Metastasis and the Department of Neurosurgery. In each lab, she sought to identify therapeutics that could prevent, reverse, or abate the neurodegenerative diseases of focus and explored mechanisms of disease development and therapeutic impact. Throughout her experiences, Annee has continually focused on developing projects driven by clinical impact and focused on taking science from bench to bedside and back.
In 2017, Annee graduated from the University of California, San Diego, from Warren College, with a Bachelor of Science in Human Biology (double minoring in Psychology and Theatre) as magna cum laude and as part of the Sigma Chapter of the Phi Beta Kappa Society and obtained a contiguous Master of Science in Biology in 2018, concentrating in Neuropathology and Scientific Communication.
Since 2014, her prior research experience includes working with various preclinical models of peripheral neuropathy (with Dr. Nigel Calcutt and Dr. Christina Sigurdson of UC San Diego’s Department of Pathology), equine and murine models of neuroaxonal dystrophy (with Dr. Carrie Finno of UC Davis’s School of Veterinary Medicine), and CNS tumor preclinical models of recurrent glioblastoma and spine tumors and metastases at Duke University Medical Center with Dr. Rory Goodwin of the Duke Center for Brain and Spine Metastasis and the Department of Neurosurgery. In each lab, she sought to identify therapeutics that could prevent, reverse, or abate the neurodegenerative diseases of focus and explored mechanisms of disease development and therapeutic impact. Throughout her experiences, Annee has continually focused on developing projects driven by clinical impact and focused on taking science from bench to bedside and back.